{{Rsnum
|rsid=6554759
|Gene=CLPTM1L
|Chromosome=5
|position=1316987
|Orientation=plus
|GMAF=0.1221
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 69.0 | 26.5 | 4.4
| HCB | 85.4 | 14.6 | 0.0
| JPT | 92.9 | 6.2 | 0.9
| YRI | 81.0 | 18.4 | 0.7
| ASW | 84.2 | 15.8 | 0.0
| CHB | 85.4 | 14.6 | 0.0
| CHD | 91.7 | 8.3 | 0.0
| GIH | 83.2 | 14.9 | 2.0
| LWK | 90.0 | 8.2 | 1.8
| MEX | 81.0 | 19.0 | 0.0
| MKK | 78.2 | 20.5 | 1.3
| TSI | 71.6 | 28.4 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=22213090
|Title=Fine-mapping of a region of chromosome 5p15.33 (TERT-CLPTM1L) suggests a novel locus in TERT and a CLPTM1L haplotype are associated with glioma susceptibility in a Chinese population
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}